Global Peptide Therapeutics Market To Grow At A CAGR Of 11% During The Forecast Period

The global peptide therapeutics market was valued at $35B in 2021 and is projected to grow at 11% CAGR during the forecast period & reaching over $74B by 2028.

Peptide therapeutics refers to disease-treating peptides. They have applications in medical fields like oncology, cardiovascular problems, pain, and urology. As of now, more than 170+ peptides are in the phase of active clinical development and more are in the pipeline.

During Covid-19, advanced peptides were created and reconfigured for effective treatment of the Covid-19 virus. Because of the efficient results shown by peptides in the treatment of Covid-19, they are being extensively researched, for any future virus or other medical conditions.

The last 2 years, i.e. 2020 and 2021 have been an eye-opener for the healthcare sector to be prepared for diseases that have a critical global impact. This has propelled the need for investing heavily in research activities for newer drug development and coming up with medical solutions for diseases that have been in existence for a long time without any medical treatments, like cancer. In fact, the global peptide therapeutics market is used extensively in the oncology segment. The rise in the number of cancer patients as well as cardiovascular diseases owing to the rising obesity index because of unhealthy lifestyle and eating habits is expected to aid the global market growth during the projection period.

The unstable nature of peptide therapeutics is likely to hamper the global market growth whereas the advent of multi-functional peptide therapeutics is likely to bring growth prospects in the coming period along with some challenges due to the shift towards proteomics, high cost of peptide therapeutics with quick expiration of patents in the global market.

The global peptide therapeutics market is segmented by route of administration, type, type of manufacturers, type of molecule, technology, application, and region

Based on the route of administration, the global market is segmented into parenteral, oral, and others. Currently, the global market is led by the parenteral mode, however, the global market is anticipated to be led by the oral mode of administration, during the forecast period.

Based on the type of manufacturers, the global market is segmented as in-house and outsourced. In-house manufacturing shares the highest market share and the same trend is anticipated during the forecast period, because of stringent rules laid down by regulatory bodies.

Based on the type of molecule, the global market is segmented as vasopressin, somatostatin, calcitonin, immunopeptide, natriuretic, and others. Immunopeptide is projected to lead the global market share because of its effective use in the treatment of tumors, and cancer.

Based on technology, the global market is segmented into liquid phase, solid phase, and hybrid phase. The largest global market share was held by the liquid phase and is expected to continue with the same trend during the forecast period.

Based on the application, the global market share was shadowed by cancer treatment previously. Since 2020, the global market share was dominated Covid-19 related treatments. However, cancer is anticipated to become the lead contributor during the forecast period.

North America is expected to dominate the global peptide therapeutics market owing to increases in the number of cases requiring medical assistance with the help of peptide therapeutics, rising geriatric population, excellent healthcare infrastructure, and increased funding from the government for research on peptide therapeutics applications.

Asia-Pacific is expected to register a significant CAGR due to the rising population and the presence of multiple healthcare facilities providing health assistance at reasonable prices with quality care.

The global peptide therapeutics market is led by key market players like Teva Pharmaceutical Industries, AstraZeneca, Sanofi S.A, Amazen Inc., Takeda Pharmaceutical, Ipsen S.A, Merck & Co., Novo Nordisk A/S, GlaxoSmithKline plc, Ever Neuro Pharma, Eli Lilly and Company, CordenPharma International.

Recent Developments:

• August 2019 witnessed the merger of Neoleukin Inc. and Aquinox Pharmaceuticals to invest in peptide therapeutics which are designed computationally. The firms intend to produce peptide-based drugs for diseases that currently do not have peptide therapeutics available for treatment.

Browse the full “Peptide Therapeutics Market By Route Of Administration (Parenteral, Oral, And Others), By Type (Innovative And Generic), By Type Of Manufacturers (In-House And Outsourced), By Type Of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, And Others), By Technology (Liquid Phase, Solid Phase, And Hybrid Phase), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/peptide-therapeutics-market

The global peptide therapeutics market is segmented as follows:

By Route of Administration

• Parenteral
• Oral
• Others

By Type:

• Innovative
• Generic

By Type of Manufacturers:

• In-house
• Outsourced

By Type of Molecule:

• Vasopressin
• Somatostatin
• Calcitonin
• Immunopeptide
• Natriuretic
• Others

By Technology:

• Liquid phase
• Solid-phase
• Hybrid phase

By Application:

• Cancer
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Infectious Disease
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com